Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001628280-23-008316

Chief Commercial Officer acquired 39,405 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Verratti Mark Chief Commercial Officer 2023-03-15 Grant or award +39,405 267,427 D
Loading xslF345X03/wf-form4_167899855540034.xml…